While modern-day science has provided the world with highly effective vaccines to fight the COVID-19 pandemic, researchers have had less luck finding effective treatment options for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Rising cases of the Delta variant, coupled with less-than-ideal vaccination rates, have made finding these post-exposure COVID-19 therapies of utmost importance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,